Loading clinical trials...
Loading clinical trials...
The aim of this study is to enhance the predictability of therapeutic success in transcatheter tricuspid valve intervention (TTVI) for patients with severe tricuspid regurgitation (TR). This will be a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Heart and Diabetes Center North-Rhine Westfalia
Collaborators
NCT07617974 · Atrial Fibrillation (AF), Tricuspid Regurgitation (TR)
NCT04761120 · Mitral Regurgitation, Tricuspid Regurgitation, and more
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT07516145 · Tricuspid Regurgitation (TR), Valvular Heart Diseases, and more
NCT07464106 · Tricuspid Regurgitation, Tricuspid Valve Insufficiency, and more
Herz- und Diabeteszentrum
Bad Oeynhausen, North Rhine-Westphalia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions